Robert M Samstein, MD, PhD
img_Robert M Samstein
ASSISTANT PROFESSOR | Radiation Oncology
Are you a patient?
Radiation Oncology
Research Topics
Anti-Tumor Therapy, Autoimmunity, Biomedical Sciences, Breast Cancer, Cancer, Cancer Genetics, Cellular Immunity, Clinical Genomics, DNA Recombination, DNA Repair, Genetics, Genomics, Immunology, Mucosal Immunology, Oncogenes, Personalized Medicine, Pharmacogenomics, T Cells, Translational Research, Tumor Suppressor Genes, Tumorigenesis
Multi-Disciplinary Training Area
Cancer Biology [CAB], Immunology [IMM]
Dr. Samstein’s research interests are focused on understanding the interaction between the patient’s immune system and cancer cells in the tumor, elucidating the role of the DNA damage repair and response pathway in altering the tumor’s ability to be recognized and attacked by the immune system. His laboratory will work to identify new strategies to harness the immune anti-tumor response and expand the therapeutic window of traditional immunotherapies.

Visit the Samstein Laboratory

MD, Weill Medical College of Cornell University

MD, Weill Cornell Medical College

PhD, Weill Cornell / Sloan Kettering / Rockefeller Tri-I MD-PhD Program

Memorial Sloan Kettering Cancer Center

Internship, Transitional Year, Memorial Sloan-Kettering Cancer Center

Residency, Radiation Oncology, Memorial Sloan-Kettering Cancer Center


Radiation Oncology


Solomon Silver Award in Clinical Medicine


American Association of Immunologists Pfizer-Showell Award


Burrough Wellcome Career Award for Medical Scientists


RSNA Roentgen Reseach Award


AACR Translational Immunology Award


American Board of Radiology Holman Research Pathway

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Samstein during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Royalty Payments:

  • Personal Genome Diagnostics

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.